Ja. Brady et al., THIAMIN STATUS, DIURETIC MEDICATIONS, AND THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE, Journal of the American Dietetic Association, 95(5), 1995, pp. 541-544
Objective To assess the prevalence of thiamin deficiency in patients w
ith congestive heart failure who are treated with diuretics that. inhi
bit sodium and chloride reabsorption in the thick ascending limb of th
e loop of Henle (loop diuretic therapy). Design A cross-sectional inve
stigation of thiamin status of consecutive patients with congestive he
art failure being treated with loop diuretic therapy. Setting Cardiolo
gy clinic of a midwestern tertiary-care medical center. Subjects Thirt
y-eight patients were recruited (mean age +/- standard deviation = 55
+/- 14 years). Validation of methodology was conducted with nine age-m
atched control subjects. Main outcome measures Thiamin status was asse
ssed biochemically by in vitro erythrocyte transketolase activity assa
y. Assessment of dietary intake of thiamin was accomplished with a sem
iquantitative food frequency questionnaire. Statistical analyses perfo
rmed Fisher's exact test and logistic regression were used to evaluate
relationships between thiamin status and variables of interest. Resul
ts Biochemical evidence of thiamin deficiency was found in 8 of 38 (21
%) patients. Evidence of risk for dietary thiamin inadequacy was found
in 10 of 38 patients (25%). Seven of the 8 patients with biochemical
evidence of thiamin deficiency met study criteria for dietary adequacy
, although quantified data suggested that only 4 of the patients achie
ved two thirds of the Recommended Dietary Allowance. Biochemical evide
nce of thiamin deficiency tended to be more common among patients with
poor left ventricular ejection fractions (P=.07). Conclusions Thiamin
deficiency may occur in a substantial proportion of patients with con
gestive heart failure, and dietary inadequacy may contribute to increa
sed risk.